The prognostic value of normal troponin on admission in STEMI patients: an 8-year multicenter cohort

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ohad Stoler

Baruch Padeh Medical Center, Tiberias (Israel)

5 More presentations in this session

Presentation thumbnail

Hs-CRP is a strong predictor of adverse cardiovascular events in patients with chest pain

Doctor B. Toprak (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

Cardiac troponin elevations across non-cardiac diseases: a comprehensive analysis

Ms S. Knudsen (Herlev, DK)

Abstract Slides Video

Presentation thumbnail

Prognostic value of cardiovascular biomarkers in patients with suspected coronary artery disease

Doctor B. Abdennadher (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

The relationship between peak serum creatine kinase levels after PCI and long-term outcomes in patients with STEMI: a report from the STELA registry

Doctor Y. Matsuda (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Lp(a) measurement in younger patients following ST-elevation myocardial infarction: insights from a contemporary regional registry.

Doctor N. Atefi (Vancouver, CA)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers in acute coronary syndromes (5)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

The prognostic utility of troponin T levels in patients undergoing PCI during initial hospitalisation for STEMI

Congress Presentation

Raised high sensitivity Troponin T (Hs-TnT) assays in non-ACS medical admissions and long term outcomes

Congress Presentation

Long-term prognosis associated with undetectable high-sensitivity cardiac troponin T concentrations in the emergency department

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources